Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
5
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 5 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Methotrexate* Methotrexate Sodium | D | $57.2M | -30% | 551,528 | $104 | $0.63 |
| Trexall Methotrexate Sodium | D | $2.3M | +10% | 1,987 | $1,168 | $41.74 |
| Methotrexate Sodium Methotrexate Sodium/PF | D | $901K | +7% | 18,556 | $49 | $1.50 |
| Methotrexate (J9260)* Methotrexate Sodium* · J9260 | B | $104K | +115% | 4,458 | $23 | $2.35 |
| Methotrexate (J8610)* Methotrexate Sodium* · J8610 | B | $4K | -17% | 115 | $31 | $0.24 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.